| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Dec 24 | RVNC Revance Therapeutics | Common Stock | Grant | Acquire A | No | No | 2.1845 | 1,000 | 2.18 k | 194,666 |
| 30 Jun 24 | RVNC Revance Therapeutics | Common Stock | Grant | Acquire A | No | No | 2.1845 | 1,000 | 2.18 k | 193,666 |
| 18 Mar 24 | RVNC Revance Therapeutics | Common Stock | Sell | Dispose S | No | No | 5.0426 | 9,361 | 47.20 k | 192,666 |
| 15 Mar 24 | RVNC Revance Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 5.305 | 3,822 | 20.28 k | 202,027 |
| 29 Feb 24 | RVNC Revance Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 17,447 | 0.00 | 205,849 |
| 31 Jan 24 | RVNC Revance Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 96,667 | 0.00 | 188,402 |
| 31 Jan 24 | RVNC Revance Therapeutics | Performance Stock Units Common Stock | Grant | Acquire A | No | No | 0 | 145,001 | 0.00 | 145,001 |
